Koschel, J.
Ray Chaudhuri, K.
Tönges, L.
Thiel, M.
Raeder, V.
Jost, W. H. http://orcid.org/0000-0002-8574-3297
Article History
Received: 26 June 2021
Accepted: 21 July 2021
First Online: 29 July 2021
Declarations
:
: JK: reports advisory board for Abbvie, honoraria for speaker from Desitin. MT: no conflict of interest. KRC: reports advisory board for AbbVie, UCB, GKC, Bial, Cynapsus, Novartis, Lobsor, Stada, Medtronic, Zambon, Profile, Sunovion, Roche, Theravance, Scion, Britannia; honoraria for lectures from AbbVie, Britannia, UCB, Mundipharma, Zambon, Novartis, Boehringer Ingelheim; Grants (Investigator Initiated) from Britannia Pharmaceuticals, AbbVie, UCB, GKC, Bial; academic grants from EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust. VR: has received funding for educational articles from Britannia pharmaceuticals. WHJ is speaker and advisor for: Abbvie, Bial, Desitin, Ipsen, Merz, Stada, UCB, and Zambon.
Free to read: This content has been made available to all.